Iconic Therapeutics, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
See more in Biomedtracker

Latest on Iconic Therapeutics, Inc.

Scrip

Deal Watch: Themis Leverages Measles Vector Platform In Collaboration With Merck & Co.

 
• By Joseph Haas and Alex Shimmings

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Themis Partners With Merck O

Scrip

Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech

 
• By Joseph Haas, Ian Haydock, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Parvus, Genentech Collaborat

Scrip

Pipeline Watch: Phase III Progress With Burosumab, Duvelisib And Galcanezumab

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

In Vivo

Execs On The Move, May 2017

 
• By Regina Paleski

Company Changes ALTMAN , Gary G., PhD To: Human Longevity Inc. , COO (May) From: G. Altman & Assoc. LLC, Managing Dir. Phone: 858-249-7500 ANDERSEN , Brian W. To: Asana Medical Inc. , CBO